Virtonomy.io is an innovative player in the Biotechnology and Health Care sectors, based in Germany. Founded in 2019, the company has quickly positioned itself as a forward-thinking startup with its digital twin technology.
Their flagship innovation, v-Patients, provides a platform for medical device developers to conduct development and testing virtually. This unique approach significantly reduces development time, lowers risks and expenses, and alleviates regulatory challenges. Utilizing a comprehensive and continuously updating database of real clinical data, Virtonomy.io captures anatomical variability, demographic diversity, and pathological conditions to enhance simulation accuracy.
In a recent funding round on 01 April 2023, the company raised €3.50M through an Early VC investment. Esteemed investors include Bayern Kapital, Brinc, N&V Capital, Springboard Health Angels, Pace Ventures, Initiative for Industrial Innovators, Accenture, and Honey Stone VC. This strategic backing underscores Virtonomy's potential within the medical innovation landscape.